Literature DB >> 28620717

Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.

Maria Pia Giannoccaro1, Anna Bartoletti-Stella2,3, Silvia Piras4, Annalisa Pession5, Patrizia De Massis6, Federico Oppi4, Michelangelo Stanzani-Maserati4, Elena Pasini4, Simone Baiardi2, Patrizia Avoni2,4, Piero Parchi2,4, Rocco Liguori2,4, Sabina Capellari7,8.   

Abstract

The C9orf72 repeat expansion (RE) is one of the most frequent causative mutations of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, it is still unclear how the C9orf72 RE can lead to a heterogeneous phenotype. Several reports have shown the coexistence of mutations in multiple ALS/FTD causative genes in the same family, suggesting an oligogenic etiology for ALS and FTD. Our aim was to investigate this phenomenon in an Italian group of ALS/FTD pedigrees carrying the C9orf72 RE. We included 11 subjects from 11 pedigrees with ALS/FTD and the C9orf72 RE. Mutation screening of FUS, SOD1 and TARDBP genes was performed by direct sequencing. A dementia-specific custom-designed targeted next-generation sequencing panel was used for screening dementia-associated genes mutations. We found genetic variants in additional ALS or dementia-related genes in four pedigrees, including the p.V47A variant in the TYROBP gene. As a group, double mutation carriers displayed a tendency toward a younger age at onset and a higher frequency of positive familiar history and of parkinsonism. Our observation supports the hypothesis that the co-presence of mutations in different genes may be relevant for the clinical expression of ALS/FTD and of their oligogenic nature.

Entities:  

Keywords:  ALS; C9orf72 repeat expansion; FTD; Oligogenic; TYROBP

Mesh:

Substances:

Year:  2017        PMID: 28620717     DOI: 10.1007/s00415-017-8540-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  62 in total

1.  C9ORF72 repeat expansions in cases with previously identified pathogenic mutations.

Authors:  Marka van Blitterswijk; Matthew C Baker; Mariely DeJesus-Hernandez; Roberta Ghidoni; Luisa Benussi; Elizabeth Finger; Ging-Yuek R Hsiung; Brendan J Kelley; Melissa E Murray; Nicola J Rutherford; Patricia E Brown; Thomas Ravenscroft; Bianca Mullen; Peter E A Ash; Kevin F Bieniek; Kimmo J Hatanpaa; Anna Karydas; Elisabeth McCarty Wood; Giovanni Coppola; Eileen H Bigio; Carol Lippa; Michael J Strong; Thomas G Beach; David S Knopman; Edward D Huey; Marsel Mesulam; Thomas Bird; Charles L White; Andrew Kertesz; Dan H Geschwind; Vivianna M Van Deerlin; Ronald C Petersen; Giuliano Binetti; Bruce L Miller; Leonard Petrucelli; Zbigniew K Wszolek; Kevin B Boylan; Neill R Graff-Radford; Ian R Mackenzie; Bradley F Boeve; Dennis W Dickson; Rosa Rademakers
Journal:  Neurology       Date:  2013-09-11       Impact factor: 9.910

2.  Brachial amyotrophic diplegia associated with the a140a superoxide dismutase 1 mutation.

Authors:  L Di Vito; D de Biase; A Pession; M Visani; R Liguori; S Zambito Marsala; V Leta; P De Carolis; V Donadio
Journal:  Neurogenetics       Date:  2013-08-16       Impact factor: 2.660

3.  Comment: double mutants of frontotemporal dementia genes--Simple co-occurrence?

Authors:  Pau Pastor
Journal:  Neurology       Date:  2013-09-11       Impact factor: 9.910

4.  Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.

Authors:  Anna Kiialainen; Karine Hovanes; Juha Paloneva; Outi Kopra; Leena Peltonen
Journal:  Neurobiol Dis       Date:  2005-03       Impact factor: 5.996

5.  A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia.

Authors:  Anna Bartoletti-Stella; Giacomo Chiaro; Giovanna Calandra-Buonaura; Manuela Contin; Cesa Scaglione; Giorgio Barletta; Annagrazia Cecere; Paolo Garagnani; Paolo Tieri; Alberto Ferrarini; Silvia Piras; Claudio Franceschi; Massimo Delledonne; Pietro Cortelli; Sabina Capellari
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

Review 6.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

7.  Aggressive familial ALS with unusual brain MRI and a SOD1 gene mutation.

Authors:  Sergiu C Blumen; Rivka Inzelberg; Puiu Nisipeanu; Ralph L Carasso; Daniel Oved; Orna Aizenstein; Vivian E Drory; Christina Bergstrom; Peter M Andersen
Journal:  Amyotroph Lateral Scler       Date:  2010

Review 8.  ALS and FTD: an epigenetic perspective.

Authors:  Veronique V Belzil; Rebecca B Katzman; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2016-06-09       Impact factor: 17.088

Review 9.  The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Rowan A Radford; Marco Morsch; Stephanie L Rayner; Nicholas J Cole; Dean L Pountney; Roger S Chung
Journal:  Front Cell Neurosci       Date:  2015-10-27       Impact factor: 5.505

10.  Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis).

Authors:  Mari Kantanen; Sari Kiuru-Enari; Oili Salonen; Markku Kaipainen; Laura Hokkanen
Journal:  PeerJ       Date:  2014-07-22       Impact factor: 2.984

View more
  10 in total

1.  Mendelian and Sporadic FTD: Disease Risk and Avenues from Genetics to Disease Pathways Through In Silico Modelling.

Authors:  Claudia Manzoni; Raffaele Ferrari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Hereditary Motor Neuropathies and Amyotrophic Lateral Sclerosis: a Molecular and Clinical Update.

Authors:  Rocio Garcia-Santibanez; Matthew Burford; Robert C Bucelli
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-17       Impact factor: 5.081

Review 3.  Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy.

Authors:  Naoki Suzuki; Ayumi Nishiyama; Hitoshi Warita; Masashi Aoki
Journal:  J Hum Genet       Date:  2022-06-13       Impact factor: 3.172

4.  The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.

Authors:  Samir Abu-Rumeileh; Sabina Capellari; Michelangelo Stanzani-Maserati; Barbara Polischi; Paolo Martinelli; Paola Caroppo; Anna Ladogana; Piero Parchi
Journal:  Alzheimers Res Ther       Date:  2018-01-11       Impact factor: 6.982

5.  Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum.

Authors:  Anna Bartoletti-Stella; Veria Vacchiano; Rocco Liguori; Sabina Capellari; Silvia De Pasqua; Giacomo Mengozzi; Dario De Biase; Ilaria Bartolomei; Patrizia Avoni; Giovanni Rizzo; Piero Parchi; Vincenzo Donadio; Adriano Chiò; Annalisa Pession; Federico Oppi; Fabrizio Salvi
Journal:  J Neurol       Date:  2021-03-26       Impact factor: 4.849

6.  Frequency of Parkinson's Disease Genes and Role of PARK2 in Amyotrophic Lateral Sclerosis: An NGS Study.

Authors:  Veria Vacchiano; Anna Bartoletti-Stella; Giovanni Rizzo; Patrizia Avoni; Piero Parchi; Fabrizio Salvi; Rocco Liguori; Sabina Capellari
Journal:  Genes (Basel)       Date:  2022-07-22       Impact factor: 4.141

7.  Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.

Authors:  Simone Baiardi; Corinne Quadalti; Angela Mammana; Sofia Dellavalle; Corrado Zenesini; Luisa Sambati; Roberta Pantieri; Barbara Polischi; Luciano Romano; Matteo Suffritti; Giuseppe Mario Bentivenga; Vanda Randi; Michelangelo Stanzani-Maserati; Sabina Capellari; Piero Parchi
Journal:  Alzheimers Res Ther       Date:  2022-10-12       Impact factor: 8.823

Review 8.  Predictive Genetic Counseling for Neurodegenerative Diseases: Past, Present, and Future.

Authors:  Jill S Goldman
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

9.  Genome sequencing for early-onset or atypical dementia: high diagnostic yield and frequent observation of multiple contributory alleles.

Authors:  Richard M Myers; Erik D Roberson; J Nicholas Cochran; Emily C McKinley; Meagan Cochran; Michelle D Amaral; Bryan A Moyers; Brittany N Lasseigne; David E Gray; James M J Lawlor; Jeremy W Prokop; Ethan G Geier; James M Holt; Michelle L Thompson; J Scott Newberry; Jennifer S Yokoyama; Elizabeth A Worthey; David S Geldmacher; Marissa Natelson Love; Gregory M Cooper
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-12-13

Review 10.  The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics.

Authors:  Hiu Chuen Lok; John B Kwok
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.